pmid	doi	year	title	Hugo_Symbol
35053500	10.3390/cancers14020338	2022	High ETV6 Levels Support Aggressive B Lymphoma Cell Survival and Predict Poor Outcome in Diffuse Large B-Cell Lymphoma Patients.	PIM2
25207815	10.1371/journal.pone.0106788	2014	Gene expression profiling identifies IRF4-associated molecular signatures in hematological malignancies.	PIM2
22722314	10.1038/bjc.2012.272	2012	PIM kinases are progression markers and emerging therapeutic targets in diffuse large B-cell lymphoma.	PIM2
22808135	10.1371/journal.pone.0040332	2012	Genome-wide detection of genes targeted by non-Ig somatic hypermutation in lymphoma.	PIM2
16373702	10.1158/1535-7163.MCT-05-0146	2005	Transcript profiling in peripheral T-cell lymphoma, not otherwise specified, and diffuse large B-cell lymphoma identifies distinct tumor profile signatures.	PIM2
12200383	10.1182/blood-2002-01-0008	2002	A molecular compendium of genes expressed in multiple myeloma.	PIM2
